Remission of refractory lupus nephritis is temporally associated with antitumour therapy, including durvalumab for endometrial carcinoma. // Annals of the Rheumatic Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S0003496726003584?dgcid=rss_sd_all
Remission of refractory lupus nephritis is temporally associated with antitumour therapy, including durvalumab for endometrial carcinoma. Annals of the Rheumatic Diseases. https://www.sciencedirect.com/science/article/pii/S0003496726003584?dgcid=rss_sd_all
“Remission of refractory lupus nephritis is temporally associated with antitumour therapy, including durvalumab for endometrial carcinoma.” Annals of the Rheumatic Diseases.
@article{article35879,
title = {Remission of refractory lupus nephritis is temporally associated with antitumour therapy, including durvalumab for endometrial carcinoma},
journal = {Annals of the Rheumatic Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S0003496726003584?dgcid=rss_sd_all}
}